Local Security Launches Product to Reduce COVID-19 Spread
Smith Rosen launches revolutionary anti-COVID, UVC technology designed for Supermarkets
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
CanadaBis Capital Grant Options
Payer-covered Digital Health Approach Improves Patient Experience and Outcomes MILWAUKEE & SEATTLE & MOUNTAIN VIEW,…
SAN FRANCISCO–(BUSINESS WIRE)–#alzheimers—Savonix, a global leader in digital cognitive health testing, and Japanese trading company…
Industry Veterans Will Lead Planned Launch of Device Designed to Provide a Safe, Rapid Solution…
BELFAST, NORTHERN IRELAND – 30 July 2020 – Liopa today announced that the company has…
FV Pharma to shut down operations within 30 days TORONTO, ON / ACCESSWIRE / July…
Sunergetic Products provides high-quality, powerful supplements with premium herbs and ingredients to create unique supplements….
— Revenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency…
TORONTO, ON / ACCESSWIRE / July 29, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) (“the…
NEW YORK–(BUSINESS WIRE)–#EHR–Earlier this month, the Electronic Health Record Association (EHRA) announced its annual Executive…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare, a leading national medical group, released a new policy white paper…
